1887

Abstract

SUMMARY

Marek’s disease virus (MDV) antigens, as detected by immunofluorescence, were induced in a lymphoblastoid cell line, MSB-1, in the presence of IdUrd. When treated with 20 µg/ml of IdUrd there was no increase in the number of cells producing virus particles. If IdUrd was removed, an increase in virus production followed. Activation of the MDV genome appeared to require incorporation of IdUrd into cellular DNA and occurred during the first 12 h of culture. Expression of the activated genome required protein synthesis and occurred during the next 12 h. The MDV genome in high producer MSB-1 cells could be activated with low concentrations of IdUrd, whereas low producer MSB-1 cells could not be activated with IdUrd to any great extent.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-34-3-413
1977-03-01
2024-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/34/3/JV0340030413.html?itemId=/content/journal/jgv/10.1099/0022-1317-34-3-413&mimeType=html&fmt=ahah

References

  1. Akiyama Y., Kato S. 1974; Two cell lines from lymphomas of Marek’s disease. Biken’s Journal 17:105–116
    [Google Scholar]
  2. Gergley L., Klein G., Ernberg I. 1971a; Appearance of EBV associated antigens in infected Raji cells. Virology 45:10–21
    [Google Scholar]
  3. Gergley L., Klein G., Ernberg I. 1971b; The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigens (EA) in Burkitt lymphoma lines. International Journal of Cancer 7:293–302
    [Google Scholar]
  4. Hampar B., Derge J. D., Martos L. M., Tagamets M. A., Chang S., Chakrabarty S. 1973; Identification of a critical period during the S phase for activation of EBV genome by 5-IUDR. Nature New Biology 244:214–217
    [Google Scholar]
  5. Hampar B., Derge J. D., Nonoyama M., Chang S., Tagamets M. A., Showalter S. D. 1974; Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine. Virology 62:71–89
    [Google Scholar]
  6. Hilgers J., Williams W. C., Meyers B. 1971; Detection of antigens of the mouse mammary tumor (MTV) and murine leukemia virus (MuLV) in cells of cultures derived from mammary tumors of mice of several strains. Virology 45:470–483
    [Google Scholar]
  7. Klein G. 1972; Herpesviruses and oncogenesis. Proceedings of the National Academy of Sciences of the United States of America 69:1056–1064
    [Google Scholar]
  8. Long C., Derge J. D., Hampar B. 1974; Procedure for activating Epstein-Barr virus early antigen in non-producer cells by 5-iododeoxyuridine. Journal of the National Cancer Institute 52:1355–1357
    [Google Scholar]
  9. Nazerian K. 1975; Induction of an early antigen of Marek’s disease virus in a lymphoblastoid cell line. In Oncogenesis and Herpesviruses II, Part I, pp. 345–350 Edited by de-The G., Epstein M. A., zur Hausen H. Lyon, France: International Agency for Research on Cancer;
    [Google Scholar]
  10. Nazerian K., Lee L. F. 1974; Deoxyribonucleic acid of Marek’s disease virus in a lymphoblastoid cell line from Marek’s disease tumour. Journal of General Virology 25:317–321
    [Google Scholar]
  11. Sugawara K., Mizuno F., Osato T. 1972; Epstein-Barr virus associated antigens in non-reproducing clones of human lymphoblastoid cell lines. Nature New Biology 239:242–243
    [Google Scholar]
  12. Sugawara K., Mizuno F., Osato T. 1973; Induction of Epstein-Barr virus related membrane antigens by 5-iododeoxyuridine in non-producer human lymphoblastoid cells. Nature, London 276:70–71
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-34-3-413
Loading
/content/journal/jgv/10.1099/0022-1317-34-3-413
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error